Sign up
Log in
Organigram says acquired Sanity holds about 10% Germany medical cannabis market share
Share
Listen to the news
Organigram says acquired Sanity holds about 10% Germany medical cannabis market share
  • Organigram reported initial post-acquisition performance from Sanity, citing about 10% average market share in Germany since the April 15, 2026 close.
  • Germany reimbursement rule changes seen as immaterial, with reimbursement-based sales about 1% of Sanity revenue.
  • Canada category positions: #1 flower 12.5% share, #1 vapes 14.5%, #2 pre-rolls 7.3%; these categories represent over 86% of retail sales.
  • End-June Canadian recreational share was 11.1%, down 0.4 percentage points year over year; up 100 basis points versus May.
  • Beverages share rose 3.1 percentage points year over year; concentrates gained 3.3 points; June all-in-one vape share improved about 1 point month over month.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OrganiGram Global Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260720180204) on July 20, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.